Detalhe da pesquisa
1.
Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma.
N Engl J Med
; 389(2): 148-157, 2023 Jul 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37272527
2.
Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network.
Lancet
; 403(10441): 2293-2306, 2024 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38705160
3.
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma.
N Engl J Med
; 386(7): 640-654, 2022 02 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34891224
4.
Ibrutinib improves survival compared with chemotherapy in mantle cell lymphoma with central nervous system relapse.
Blood
; 140(17): 1907-1916, 2022 10 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35789260
5.
Earlier corticosteroid use for adverse event management in patients receiving axicabtagene ciloleucel for large B-cell lymphoma.
Br J Haematol
; 195(3): 388-398, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34590303
6.
Prophylactic corticosteroid use in patients receiving axicabtagene ciloleucel for large B-cell lymphoma.
Br J Haematol
; 194(4): 690-700, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34296427
7.
Interim thymus and activation regulated chemokine versus interim 18 F-fluorodeoxyglucose positron-emission tomography in classical Hodgkin lymphoma response evaluation.
Br J Haematol
; 190(1): 40-44, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32106342
8.
Tumour necrosis as assessed with 18F-FDG PET is a potential prognostic marker in diffuse large B cell lymphoma independent of MYC rearrangements.
Eur Radiol
; 29(11): 6018-6028, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31028445
9.
Heterogeneous Pattern of Dependence on Anti-Apoptotic BCL-2 Family Proteins upon CHOP Treatment in Diffuse Large B-Cell Lymphoma.
Int J Mol Sci
; 20(23)2019 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31801186
10.
High frequency of hyperglycaemia observed during CAR T-cell treatment.
Diabet Med
; 40(2): e14969, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36209376
11.
Type I CD20 Antibodies Recruit the B Cell Receptor for Complement-Dependent Lysis of Malignant B Cells.
J Immunol
; 197(12): 4829-4837, 2016 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27807190
12.
Target antigen density governs the efficacy of anti-CD20-CD28-CD3 ζ chimeric antigen receptor-modified effector CD8+ T cells.
J Immunol
; 194(3): 911-20, 2015 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25520398
13.
Reducing and controlling metabolic active tumor volume prior to CAR T-cell infusion can improve survival outcomes in patients with large B-cell lymphoma.
Blood Cancer J
; 14(1): 41, 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38448432
14.
VISTA drives macrophages towards a pro-tumoral phenotype that promotes cancer cell phagocytosis yet down-regulates T cell responses.
Exp Hematol Oncol
; 13(1): 35, 2024 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38553748
15.
Long-term outcomes of patients with large B-cell lymphoma treated with axicabtagene ciloleucel and prophylactic corticosteroids.
Bone Marrow Transplant
; 59(3): 366-372, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38177222
16.
Combined PD-1 and JAK1/2 inhibition in refractory primary mediastinal B-cell lymphoma.
Ann Hematol
; 97(5): 905-907, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29327077
17.
Semi-automated 18F-FDG PET segmentation methods for tumor volume determination in Non-Hodgkin lymphoma patients: a literature review, implementation and multi-threshold evaluation.
Comput Struct Biotechnol J
; 21: 1102-1114, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36789266
18.
Development of a Core Set of Patient- and Caregiver-Reported Signs and Symptoms to Facilitate Early Recognition of Acute Chimeric Antigen Receptor T-Cell Therapy Toxicities.
JCO Oncol Pract
; 19(3): e407-e416, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36508702
19.
Safety and Efficacy of Axicabtagene Ciloleucel versus Standard of Care in Patients 65 Years of Age or Older with Relapsed/Refractory Large B-Cell Lymphoma.
Clin Cancer Res
; 29(10): 1894-1905, 2023 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36999993
20.
Population-Based External Validation of the EASIX Scores to Predict CAR T-Cell-Related Toxicities.
Cancers (Basel)
; 15(22)2023 Nov 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38001703